SYNAERION Trademark

Trademark Overview


On Monday, April 5, 2021, a trademark application was filed for SYNAERION with the United States Patent and Trademark Office. The USPTO has given the SYNAERION trademark a serial number of 90624333. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 26, 2022. This trademark is owned by Synaerion Therapeutics, Inc.. The SYNAERION trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biological preparations for the treatment of central nervous system disorders and cancer; Pharmaceutical preparations for the treatment of central nervous system disorders and cancer

Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical laboratory services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of central nervous system and oncology disorders; Scientific and technological services, namely, scientific research, analysis, development, testing, and providing clinical trials in the field of pharmaceuticals for the diagnosis and treatment of central nervous system disorders and oncology disorders
synaerion

General Information


Serial Number90624333
Word MarkSYNAERION
Filing DateMonday, April 5, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 26, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 28, 2021

Trademark Statements


Goods and ServicesBiological preparations for the treatment of central nervous system disorders and cancer; Pharmaceutical preparations for the treatment of central nervous system disorders and cancer
Goods and ServicesConsulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical laboratory services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of central nervous system and oncology disorders; Scientific and technological services, namely, scientific research, analysis, development, testing, and providing clinical trials in the field of pharmaceuticals for the diagnosis and treatment of central nervous system disorders and oncology disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 12, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSynaerion Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilliamstown, NJ 08094

Party NameSynaerion Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilliamstown, NJ 08094

Trademark Events


Event DateEvent Description
Monday, September 26, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 26, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 28, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 18, 2021ASSIGNED TO EXAMINER
Monday, July 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 8, 2021NEW APPLICATION ENTERED IN TRAM